Coya Therapeutics, Inc.
Coya Therapeutics, Inc. (COYA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
coya · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Coya Therapeutics, Inc. (COYA) measures how much investors pay for each dollar of the company's trailing earnings. COYA's current PE ratio of N/A is calculated by dividing its stock price of $4.61 by its TTM earnings per share of -$1.26.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Coya Therapeutics, Inc.You COYA | $84M | N/A | — | -$1.26 |
 Clene Inc. CLNN | $58M | N/A | — | -$2.65 |
 Context Therapeutics Inc. CNTX | $154M | N/A | — | -$0.38 |
 Immix Biopharma, Inc. IMMX | $435M | N/A | — | -$0.89 |
 MacroGenics, Inc. MGNX | $257M | N/A | — | -$1.18 |
 Oramed Pharmaceuticals Inc. ORMP | $152M | 1.84x | — | $1.55 |
 Ovid Therapeutics Inc. OVID | $317M | N/A | — | -$0.24 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.27 | — | |
2024-12-31 FY2024 | — | $-0.98 | — | |
2023-12-31 FY2023 | — | $-0.79 | — | |
2022-12-31 FY2022 | — | $-1.23 | — | |
2021-12-31 FY2021 | — | $-0.74 | — | |
2020-12-31 FY2020 | — | $-0.42 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Coya Therapeutics, Inc. (COYA) measures how much investors pay for each dollar of the company's trailing earnings. COYA's current PE ratio of N/A is calculated by dividing its stock price of $4.61 by its TTM earnings per share of -$1.26.
Frequently asked questions
COYA pe ratio · 6 questionsCOYA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.61 and TTM EPS of -$1.26. Data sourced from Financial Modeling Prep via COYA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Coya Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09